Radiosensitized treatment of malignant brain tumors

Laima Bloznelyte-Plesniene M.D.

doi:10.1117/12.544911

12 December 2003 Radiosensitized treatment of malignant brain tumors

Laima Bloznelyte-Plesniene M.D.

Proceedings Volume 5287, Laser Florence 2002: A Window on the Laser Medicine World; (2003) https://doi.org/10.1117/12.544911
Event: Laser Florence 2002: A Window on the Laser Medicine World, 2002, Florence, Italy

Abstract

Around 12,000 deaths from glioblastoma occurs within the European Community annually. At present, the best available treatment for malignant brain tumors results in a median survival of patients of 15 months despite surgery, radiotherapy, and chemotherapy. The purpose of this paper is to review our results of radiosensitized treatment of malignant brain tumors.

Citation Download Citation

Laima Bloznelyte-Plesniene M.D. "Radiosensitized treatment of malignant brain tumors", Proc. SPIE 5287, Laser Florence 2002: A Window on the Laser Medicine World, (12 December 2003); https://doi.org/10.1117/12.544911

ACCESS THE FULL ARTICLE

INSTITUTIONAL
Select your institution to access the SPIE Digital Library.

SELECT YOUR INSTITUTION

PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.

PERSONAL SIGN IN

No SPIE Account? Create one

PURCHASE THIS CONTENT

SUBSCRIBE TO DIGITAL LIBRARY

50 downloads per 1-year subscription

Members: $195

Non-members: $335 ADD TO CART

25 downloads per 1 - year subscription

Members: $145

Non-members: $250 ADD TO CART

PURCHASE SINGLE ARTICLE

Includes PDF, HTML & Video, when available